INTERCEPT PHARMACEUTICALS IN

CUSIP: 45845PAA6 Class: NOTE 3.250% 7/0

GABELLI & Co INVESTMENT ADVISERS, INC.'s Holding History (CIK: 0000932724)

Note: Option positions (PUT/CALL) are excluded.

Q3 2020
Shares 200,000 Value ($000) $161 Avg Close — Range —
Q2 2020
Shares 200,000 Value ($000) $151 Avg Close — Range —
Q1 2020
Shares 200,000 Value ($000) $163 Avg Close — Range —
Q4 2019
Shares 200,000 Value ($000) $202 Avg Close — Range —
Q3 2019
Shares 200,000 Value ($000) $172 Avg Close — Range —
Q2 2019
Shares 200,000 Value ($000) $178 Avg Close — Range —
Q1 2019
Shares 200,000 Value ($000) $198 Avg Close — Range —
Q4 2018
Shares 200,000 Value ($000) $185 Avg Close — Range —
Q3 2018
Shares 200,000 Value ($000) $202 Avg Close — Range —
Q2 2018
Shares 200,000 Value ($000) $176 Avg Close — Range —
Q1 2018
Shares 200,000 Value ($000) $161 Avg Close — Range —
Q4 2017
Shares 200,000 Value ($000) $161 Avg Close — Range —